Melola Discovery

← Melola Discovery

Journal

Studi in Silico Senyawa Metabolit Sekunder Daun Kenikir (Cosmos Caudatus Kunth.) Sebagai Antikanker Ovarium terhadap ESR-1

Indonesian Journal of Mathematics and Natural Sciences · Vol. 47 No. 2 (2024) · pp. 85–98

DOI
10.15294/s43fsj13
ISSN
2774-7832
Published
2024-10-11
Publisher
Universitas Negeri Semarang
Language
eng

Abstract

Ovarian cancer is one of the diseases with a high mortality rate through estrogen receptor alpha (ESR1) as one of the causes of ovarian cancer. Current therapies for ovarian cancer can cause side effects and are expensive. Therefore, alternative therapies with fewer side effects and more affordable costs are needed. One of the herbs that is rich in flavonoid and phenolic acid content which has anticancer activity with its mechanism as a trigger for apoptosis in ovarian cancer cells is Kenikir leaf (Cosmos caudatus). The study was conducted through pharmacophore screening and molecular docking methods in silico with ESR-1 receptor (PDB code:1SJ0). In addition, absorption, distribution, and toxicity predictions were also carried out through the PreADMET page and the Lipinski Rule of Five suitability test. The results of this study concluded that luteolin is the most potential compound as an ESR-1 receptor inhibitor with a pharmacophore fit-score value of 51.36, binding energy of -8.43 kcal/mol, inhibition constant of 66.366x10-2 µM, and hydrogen bonds as ligand-receptor interactions.

Keywords

Collaboration network of the authors

11 authors · 34 co-authorship links

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Rizky Prasiska WulandariAffiliation unknown1
Halwa Aulia NurdinAffiliation unknown1
Diffa Hauna F. PakhrulAffiliation unknown1
Sabiq Salmandhiya HaritsAffiliation unknown1
Natasya PrameswariAffiliation unknown1
Alya Puteri Agustina PribadiAffiliation unknown1
Diah Lia AulifaAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) https://journal.unnes.ac.id/journals/JM/oai, first harvested 5 Nov 2026, last seen 8 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Studi in Silico Senyawa Metabolit Sekunder Daun Kenikir (Cosmos Caudatus Kunth.) Sebagai Antikanker Ovarium terhadap ESR-1</dc:title>
	<dc:creator xml:lang="en">Gabriel, Kevin</dc:creator>
	<dc:creator xml:lang="en">Hidayat, Nafisa Nurfatia </dc:creator>
	<dc:creator xml:lang="en">Khaerani, Fitri Azlia </dc:creator>
	<dc:creator xml:lang="en">Gaharani , Prodio Efa </dc:creator>
	<dc:subject xml:lang="en">ESR1</dc:subject>
	<dc:subject xml:lang="en">in silico study</dc:subject>
	<dc:subject xml:lang="en">kenikir leaves</dc:subject>
	<dc:subject xml:lang="en">molecular docking</dc:subject>
	<dc:subject xml:lang="en">ovarian cancer </dc:subject>
	<dc:description xml:lang="en">Ovarian cancer is one of the diseases with a high mortality rate through estrogen receptor alpha (ESR1) as one of the causes of ovarian cancer. Current therapies for ovarian cancer can cause side effects and are expensive. Therefore, alternative therapies with fewer side effects and more affordable costs are needed.  One of the herbs that is rich in flavonoid and phenolic acid content which has anticancer activity with its mechanism as a trigger for apoptosis in ovarian cancer cells is Kenikir leaf (Cosmos caudatus). The study was conducted through pharmacophore screening and molecular docking methods in silico with ESR-1 receptor (PDB code:1SJ0). In addition, absorption, distribution, and toxicity predictions were also carried out through the PreADMET page and the Lipinski Rule of Five suitability test. The results of this study concluded that luteolin is the most potential compound as an ESR-1 receptor inhibitor with a pharmacophore fit-score value of 51.36, binding energy of -8.43 kcal/mol, inhibition constant of 66.366x10-2 µM, and hydrogen bonds as ligand-receptor interactions.</dc:description>
	<dc:publisher xml:lang="en">Universitas Negeri Semarang</dc:publisher>
	<dc:date>2024-10-11</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.unnes.ac.id/journals/JM/article/view/14793</dc:identifier>
	<dc:identifier>10.15294/s43fsj13</dc:identifier>
	<dc:source xml:lang="en">Indonesian Journal of Mathematics and Natural Sciences; Vol. 47 No. 2 (2024): Volume 47 Nomor 2 Tahun 2024; 85-98</dc:source>
	<dc:source>2774-7832</dc:source>
	<dc:source>10.15294/57dzv753</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.unnes.ac.id/journals/JM/article/view/14793/1665</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2024 Indonesian Journal of Mathematics and Natural Sciences</dc:rights>
</oai_dc:dc>